FMBTD
SAGE icon

First Midwest Bank Trust Division’s Sage Therapeutics SAGE Stock Holding History

First Midwest Bank Trust Division’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,644
Closed -$352K – 442
2017
Q3 		$352K Buy
5,644
+110
+2% +$8.64K 0.04% 379
2017
Q2 		$441K Buy
+5,534
New +$400K 0.05% 344
2017
Q1 		– Sell
-17,219
Closed -$879K – 458
2016
Q4 		$879K Sell
17,219
-200
-1% -$9.43K 0.11% 233
2016
Q3 		$802K Buy
+17,419
New +$709K 0.1% 236

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

First Midwest Bank Trust Division's SAGE Position: Q4 2017 in Review

First Midwest Bank Trust Division sold out of Sage Therapeutics (SAGE) in Q4 2017, closing a stake of 5,644 shares — an estimated $352K sold.

First Midwest Bank Trust Division first reported a position in SAGE in Q3 2016 and held it in 4 quarters. The position peaked at $879K in Q4 2016. 224 funds tracked by Wall St. Rank hold SAGE as of Q4 2017.

  • First Midwest Bank Trust Division reported no remaining Sage Therapeutics position as of Q4 2017 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 5,644 Sage Therapeutics shares in Q4 2017, an estimated $352K.
  • First Midwest Bank Trust Division first reported a position in Sage Therapeutics in Q3 2016 and held it in 4 quarters.
  • First Midwest Bank Trust Division's Sage Therapeutics position peaked at $879K in Q4 2016.
  • 224 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2017.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2017, filed 2 Feb 2018.